Management of HSV in cancer patients requires a multifaceted approach. Prophylactic antiviral medications such as acyclovir or valacyclovir are often prescribed to prevent outbreaks. Additionally, maintaining a robust immune system through adequate nutrition and supportive care is critical to minimizing the risk of HSV reactivation.
